Peter J Barris's Net Worth
Estimate Recalculated Aug 1, 2025 08:14PM EST
Who is Peter J Barris
Peter J Barris has an estimated net worth of $3.08 Million. This is based on reported shares across multiple companies, which include GLU MOBILE INC, SUNESIS PHARMACEUTICALS INC, MOTRICITY INC, SOURCEFIRE INC, BOINGO WIRELESS INC, AUDIENCE INC, PEPLIN INC, ARYx Therapeutics, Inc., Data Domain, Inc., IOMAI CORP, OCCAM NETWORKS INC/DE, PHARMOS CORP, SUPERNUS PHARMACEUTICALS INC, HEMOSENSE INC, Cloudflare, Inc., RHYTHM PHARMACEUTICALS, INC., OPOWER, INC., Cascadian Therapeutics, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, Echo Global Logistics, Inc., Financial Engines, Inc., FUSION-IO, INC., MULESOFT, INC, Groupon, Inc., TriVascular Technologies, Inc., INNERWORKINGS INC, HYPERION THERAPEUTICS INC, Elastic N.V., Senseonics Holdings, Inc., Berkshire Grey, Inc., NEXTNAV INC., CHANNELADVISOR CORP, ZHONE TECHNOLOGIES INC, Bloom Energy Corp, Oyster Point Pharma, Inc., AVEO PHARMACEUTICALS INC, Zosano Pharma Corp, Sprout Social, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Clovis Oncology, Inc., Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, AMICUS THERAPEUTICS INC, VONAGE HOLDINGS CORP, BOX INC, Nightstar Therapeutics plc, Tintri, Inc., Loxo Oncology, Inc., Dermira, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., TREVENA INC, GENOCEA BIOSCIENCES, INC., PhaseBio Pharmaceuticals Inc, Millendo Therapeutics, Inc., TARGACEPT INC, TESARO, Inc., PROTEOSTASIS THERAPEUTICS, INC., ARDELYX, INC., Galera Therapeutics, Inc., Trevi Therapeutics, Inc., GLYCOMIMETICS INC, Tracon Pharmaceuticals, Inc., Mirna Therapeutics, Inc., Epizyme, Inc., Arsanis, Inc., NOVACEA INC, Cerecor Inc., Roka BioScience, Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., Marker Therapeutics, Inc., Omthera Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., ZeroFox Holdings, Inc., Tableau Software Inc, Neutral Tandem Inc, Strongbridge Biopharma plc, CVENT INC, Achaogen Inc, Vitae Pharmaceuticals, Inc, XOOM Corp, Liquidia Technologies Inc, ARADIGM CORP, XTERA COMMUNICATIONS, INC., INTERLEUKIN GENETICS INC, INHIBITEX INC, INTARCIA THERAPEUTICS, INC, FOXHOLLOW TECHNOLOGIES, INC., PHARMION CORP, MYOGEN INC, ZTI MERGER SUBSIDIARY III INC, APPLIED IMAGING CORP, and Tempus AI, Inc..
SEC CIK
Peter J Barris's CIK is 0001005561
Past Insider Trading and Trends
2012 was Peter J Barris's most active year for acquiring shares with 14 total transactions. Peter J Barris's most active month to acquire stocks was the month of May. 2013 was Peter J Barris's most active year for disposing of shares, totalling 2 transactions. Peter J Barris's most active month to dispose stocks was the month of May. 2024 saw Peter J Barris paying a total of $0.00 for 119,126 shares, this is the most they've acquired in one year. In 2019 Peter J Barris cashed out on 210,124 shares for a total of $490,954.73, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
